nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Hypotension—Pamidronate—osteoporosis	0.000657	0.000657	CcSEcCtD
Gadoversetamide—Convulsion—Conjugated Estrogens—osteoporosis	0.000656	0.000656	CcSEcCtD
Gadoversetamide—Dry mouth—Zoledronate—osteoporosis	0.000655	0.000655	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000655	0.000655	CcSEcCtD
Gadoversetamide—Fatigue—Ethinyl Estradiol—osteoporosis	0.000654	0.000654	CcSEcCtD
Gadoversetamide—Pruritus—Alendronate—osteoporosis	0.000652	0.000652	CcSEcCtD
Gadoversetamide—Dyspepsia—Risedronate—osteoporosis	0.000651	0.000651	CcSEcCtD
Gadoversetamide—Eye disorder—Estradiol—osteoporosis	0.000651	0.000651	CcSEcCtD
Gadoversetamide—Tinnitus—Estradiol—osteoporosis	0.000649	0.000649	CcSEcCtD
Gadoversetamide—Constipation—Ethinyl Estradiol—osteoporosis	0.000649	0.000649	CcSEcCtD
Gadoversetamide—Confusional state—Zoledronate—osteoporosis	0.000647	0.000647	CcSEcCtD
Gadoversetamide—Hypersensitivity—Calcitriol—osteoporosis	0.000647	0.000647	CcSEcCtD
Gadoversetamide—Flushing—Estradiol—osteoporosis	0.000646	0.000646	CcSEcCtD
Gadoversetamide—Cardiac disorder—Estradiol—osteoporosis	0.000646	0.000646	CcSEcCtD
Gadoversetamide—Chest pain—Conjugated Estrogens—osteoporosis	0.000645	0.000645	CcSEcCtD
Gadoversetamide—Myalgia—Conjugated Estrogens—osteoporosis	0.000645	0.000645	CcSEcCtD
Gadoversetamide—Arthralgia—Conjugated Estrogens—osteoporosis	0.000645	0.000645	CcSEcCtD
Gadoversetamide—Asthenia—Ibandronate—osteoporosis	0.000644	0.000644	CcSEcCtD
Gadoversetamide—Anxiety—Conjugated Estrogens—osteoporosis	0.000643	0.000643	CcSEcCtD
Gadoversetamide—Nausea—Etidronic acid—osteoporosis	0.000642	0.000642	CcSEcCtD
Gadoversetamide—Oedema—Zoledronate—osteoporosis	0.000642	0.000642	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Zoledronate—osteoporosis	0.000642	0.000642	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00064	0.00064	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00064	0.00064	CcSEcCtD
Gadoversetamide—Diarrhoea—Estropipate—osteoporosis	0.00064	0.00064	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Risedronate—osteoporosis	0.000638	0.000638	CcSEcCtD
Gadoversetamide—Fatigue—Risedronate—osteoporosis	0.000637	0.000637	CcSEcCtD
Gadoversetamide—Insomnia—Pamidronate—osteoporosis	0.000636	0.000636	CcSEcCtD
Gadoversetamide—Pruritus—Ibandronate—osteoporosis	0.000635	0.000635	CcSEcCtD
Gadoversetamide—Constipation—Risedronate—osteoporosis	0.000632	0.000632	CcSEcCtD
Gadoversetamide—Pain—Risedronate—osteoporosis	0.000632	0.000632	CcSEcCtD
Gadoversetamide—Angiopathy—Estradiol—osteoporosis	0.000632	0.000632	CcSEcCtD
Gadoversetamide—Shock—Zoledronate—osteoporosis	0.000632	0.000632	CcSEcCtD
Gadoversetamide—Paraesthesia—Pamidronate—osteoporosis	0.000631	0.000631	CcSEcCtD
Gadoversetamide—Diarrhoea—Alendronate—osteoporosis	0.000631	0.000631	CcSEcCtD
Gadoversetamide—Asthenia—Calcitriol—osteoporosis	0.00063	0.00063	CcSEcCtD
Gadoversetamide—Nervous system disorder—Zoledronate—osteoporosis	0.00063	0.00063	CcSEcCtD
Gadoversetamide—Immune system disorder—Estradiol—osteoporosis	0.000629	0.000629	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Zoledronate—osteoporosis	0.000629	0.000629	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Estradiol—osteoporosis	0.000628	0.000628	CcSEcCtD
Gadoversetamide—Dyspnoea—Pamidronate—osteoporosis	0.000627	0.000627	CcSEcCtD
Gadoversetamide—Tachycardia—Zoledronate—osteoporosis	0.000627	0.000627	CcSEcCtD
Gadoversetamide—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000625	0.000625	CcSEcCtD
Gadoversetamide—Chills—Estradiol—osteoporosis	0.000625	0.000625	CcSEcCtD
Gadoversetamide—Somnolence—Pamidronate—osteoporosis	0.000625	0.000625	CcSEcCtD
Gadoversetamide—Skin disorder—Zoledronate—osteoporosis	0.000624	0.000624	CcSEcCtD
Gadoversetamide—Pruritus—Calcitriol—osteoporosis	0.000621	0.000621	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Zoledronate—osteoporosis	0.000621	0.000621	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00062	0.00062	CcSEcCtD
Gadoversetamide—Diarrhoea—Raloxifene—osteoporosis	0.00062	0.00062	CcSEcCtD
Gadoversetamide—Dyspepsia—Pamidronate—osteoporosis	0.000619	0.000619	CcSEcCtD
Gadoversetamide—Dizziness—Estropipate—osteoporosis	0.000619	0.000619	CcSEcCtD
Gadoversetamide—Oedema—Conjugated Estrogens—osteoporosis	0.000618	0.000618	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000618	0.000618	CcSEcCtD
Gadoversetamide—Diarrhoea—Ibandronate—osteoporosis	0.000614	0.000614	CcSEcCtD
Gadoversetamide—Anorexia—Zoledronate—osteoporosis	0.000612	0.000612	CcSEcCtD
Gadoversetamide—Decreased appetite—Pamidronate—osteoporosis	0.000611	0.000611	CcSEcCtD
Gadoversetamide—Mental disorder—Estradiol—osteoporosis	0.00061	0.00061	CcSEcCtD
Gadoversetamide—Dizziness—Alendronate—osteoporosis	0.000609	0.000609	CcSEcCtD
Gadoversetamide—Shock—Conjugated Estrogens—osteoporosis	0.000608	0.000608	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000607	0.000607	CcSEcCtD
Gadoversetamide—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000606	0.000606	CcSEcCtD
Gadoversetamide—Malnutrition—Estradiol—osteoporosis	0.000606	0.000606	CcSEcCtD
Gadoversetamide—Erythema—Estradiol—osteoporosis	0.000606	0.000606	CcSEcCtD
Gadoversetamide—Fatigue—Pamidronate—osteoporosis	0.000606	0.000606	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Risedronate—osteoporosis	0.000605	0.000605	CcSEcCtD
Gadoversetamide—Tachycardia—Conjugated Estrogens—osteoporosis	0.000603	0.000603	CcSEcCtD
Gadoversetamide—Urticaria—Ethinyl Estradiol—osteoporosis	0.000602	0.000602	CcSEcCtD
Gadoversetamide—Pain—Pamidronate—osteoporosis	0.000601	0.000601	CcSEcCtD
Gadoversetamide—Constipation—Pamidronate—osteoporosis	0.000601	0.000601	CcSEcCtD
Gadoversetamide—Diarrhoea—Calcitriol—osteoporosis	0.000601	0.000601	CcSEcCtD
Gadoversetamide—Skin disorder—Conjugated Estrogens—osteoporosis	0.0006	0.0006	CcSEcCtD
Gadoversetamide—Hypotension—Zoledronate—osteoporosis	0.0006	0.0006	CcSEcCtD
Gadoversetamide—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.0006	0.0006	CcSEcCtD
Gadoversetamide—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.0006	0.0006	CcSEcCtD
Gadoversetamide—Dizziness—Raloxifene—osteoporosis	0.000599	0.000599	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000598	0.000598	CcSEcCtD
Gadoversetamide—Flatulence—Estradiol—osteoporosis	0.000597	0.000597	CcSEcCtD
Gadoversetamide—Tension—Estradiol—osteoporosis	0.000595	0.000595	CcSEcCtD
Gadoversetamide—Vomiting—Estropipate—osteoporosis	0.000595	0.000595	CcSEcCtD
Gadoversetamide—Dysgeusia—Estradiol—osteoporosis	0.000594	0.000594	CcSEcCtD
Gadoversetamide—Dizziness—Ibandronate—osteoporosis	0.000593	0.000593	CcSEcCtD
Gadoversetamide—Rash—Estropipate—osteoporosis	0.00059	0.00059	CcSEcCtD
Gadoversetamide—Dermatitis—Estropipate—osteoporosis	0.000589	0.000589	CcSEcCtD
Gadoversetamide—Anorexia—Conjugated Estrogens—osteoporosis	0.000589	0.000589	CcSEcCtD
Gadoversetamide—Nervousness—Estradiol—osteoporosis	0.000589	0.000589	CcSEcCtD
Gadoversetamide—Urticaria—Risedronate—osteoporosis	0.000587	0.000587	CcSEcCtD
Gadoversetamide—Back pain—Estradiol—osteoporosis	0.000586	0.000586	CcSEcCtD
Gadoversetamide—Headache—Estropipate—osteoporosis	0.000586	0.000586	CcSEcCtD
Gadoversetamide—Vomiting—Alendronate—osteoporosis	0.000586	0.000586	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000585	0.000585	CcSEcCtD
Gadoversetamide—Body temperature increased—Risedronate—osteoporosis	0.000585	0.000585	CcSEcCtD
Gadoversetamide—Abdominal pain—Risedronate—osteoporosis	0.000585	0.000585	CcSEcCtD
Gadoversetamide—Muscle spasms—Estradiol—osteoporosis	0.000583	0.000583	CcSEcCtD
Gadoversetamide—Rash—Alendronate—osteoporosis	0.000581	0.000581	CcSEcCtD
Gadoversetamide—Insomnia—Zoledronate—osteoporosis	0.000581	0.000581	CcSEcCtD
Gadoversetamide—Dermatitis—Alendronate—osteoporosis	0.000581	0.000581	CcSEcCtD
Gadoversetamide—Feeling abnormal—Pamidronate—osteoporosis	0.000579	0.000579	CcSEcCtD
Gadoversetamide—Hypotension—Conjugated Estrogens—osteoporosis	0.000578	0.000578	CcSEcCtD
Gadoversetamide—Headache—Alendronate—osteoporosis	0.000577	0.000577	CcSEcCtD
Gadoversetamide—Paraesthesia—Zoledronate—osteoporosis	0.000577	0.000577	CcSEcCtD
Gadoversetamide—Vomiting—Raloxifene—osteoporosis	0.000576	0.000576	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Pamidronate—osteoporosis	0.000575	0.000575	CcSEcCtD
Gadoversetamide—Dyspnoea—Zoledronate—osteoporosis	0.000572	0.000572	CcSEcCtD
Gadoversetamide—Rash—Raloxifene—osteoporosis	0.000571	0.000571	CcSEcCtD
Gadoversetamide—Dermatitis—Raloxifene—osteoporosis	0.000571	0.000571	CcSEcCtD
Gadoversetamide—Somnolence—Zoledronate—osteoporosis	0.000571	0.000571	CcSEcCtD
Gadoversetamide—Vomiting—Ibandronate—osteoporosis	0.00057	0.00057	CcSEcCtD
Gadoversetamide—Tremor—Estradiol—osteoporosis	0.000568	0.000568	CcSEcCtD
Gadoversetamide—Headache—Raloxifene—osteoporosis	0.000568	0.000568	CcSEcCtD
Gadoversetamide—Rash—Ibandronate—osteoporosis	0.000566	0.000566	CcSEcCtD
Gadoversetamide—Dermatitis—Ibandronate—osteoporosis	0.000565	0.000565	CcSEcCtD
Gadoversetamide—Dyspepsia—Zoledronate—osteoporosis	0.000565	0.000565	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000563	0.000563	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Estradiol—osteoporosis	0.000563	0.000563	CcSEcCtD
Gadoversetamide—Headache—Ibandronate—osteoporosis	0.000562	0.000562	CcSEcCtD
Gadoversetamide—Insomnia—Conjugated Estrogens—osteoporosis	0.000559	0.000559	CcSEcCtD
Gadoversetamide—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000559	0.000559	CcSEcCtD
Gadoversetamide—Vomiting—Calcitriol—osteoporosis	0.000558	0.000558	CcSEcCtD
Gadoversetamide—Decreased appetite—Zoledronate—osteoporosis	0.000558	0.000558	CcSEcCtD
Gadoversetamide—Agitation—Estradiol—osteoporosis	0.000557	0.000557	CcSEcCtD
Gadoversetamide—Nausea—Estropipate—osteoporosis	0.000556	0.000556	CcSEcCtD
Gadoversetamide—Abdominal pain—Pamidronate—osteoporosis	0.000556	0.000556	CcSEcCtD
Gadoversetamide—Body temperature increased—Pamidronate—osteoporosis	0.000556	0.000556	CcSEcCtD
Gadoversetamide—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000555	0.000555	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000554	0.000554	CcSEcCtD
Gadoversetamide—Rash—Calcitriol—osteoporosis	0.000554	0.000554	CcSEcCtD
Gadoversetamide—Fatigue—Zoledronate—osteoporosis	0.000554	0.000554	CcSEcCtD
Gadoversetamide—Dermatitis—Calcitriol—osteoporosis	0.000553	0.000553	CcSEcCtD
Gadoversetamide—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000551	0.000551	CcSEcCtD
Gadoversetamide—Headache—Calcitriol—osteoporosis	0.00055	0.00055	CcSEcCtD
Gadoversetamide—Somnolence—Conjugated Estrogens—osteoporosis	0.00055	0.00055	CcSEcCtD
Gadoversetamide—Pain—Zoledronate—osteoporosis	0.000549	0.000549	CcSEcCtD
Gadoversetamide—Constipation—Zoledronate—osteoporosis	0.000549	0.000549	CcSEcCtD
Gadoversetamide—Nausea—Alendronate—osteoporosis	0.000547	0.000547	CcSEcCtD
Gadoversetamide—Malaise—Estradiol—osteoporosis	0.000547	0.000547	CcSEcCtD
Gadoversetamide—Hypersensitivity—Risedronate—osteoporosis	0.000545	0.000545	CcSEcCtD
Gadoversetamide—Vertigo—Estradiol—osteoporosis	0.000545	0.000545	CcSEcCtD
Gadoversetamide—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000544	0.000544	CcSEcCtD
Gadoversetamide—Asthenia—Ethinyl Estradiol—osteoporosis	0.000544	0.000544	CcSEcCtD
Gadoversetamide—Syncope—Estradiol—osteoporosis	0.000544	0.000544	CcSEcCtD
Gadoversetamide—Nausea—Raloxifene—osteoporosis	0.000538	0.000538	CcSEcCtD
Gadoversetamide—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000537	0.000537	CcSEcCtD
Gadoversetamide—Pruritus—Ethinyl Estradiol—osteoporosis	0.000537	0.000537	CcSEcCtD
Gadoversetamide—Palpitations—Estradiol—osteoporosis	0.000536	0.000536	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000534	0.000534	CcSEcCtD
Gadoversetamide—Fatigue—Conjugated Estrogens—osteoporosis	0.000533	0.000533	CcSEcCtD
Gadoversetamide—Nausea—Ibandronate—osteoporosis	0.000533	0.000533	CcSEcCtD
Gadoversetamide—Loss of consciousness—Estradiol—osteoporosis	0.000533	0.000533	CcSEcCtD
Gadoversetamide—Asthenia—Risedronate—osteoporosis	0.000531	0.000531	CcSEcCtD
Gadoversetamide—Feeling abnormal—Zoledronate—osteoporosis	0.000529	0.000529	CcSEcCtD
Gadoversetamide—Cough—Estradiol—osteoporosis	0.000529	0.000529	CcSEcCtD
Gadoversetamide—Constipation—Conjugated Estrogens—osteoporosis	0.000529	0.000529	CcSEcCtD
Gadoversetamide—Pain—Conjugated Estrogens—osteoporosis	0.000529	0.000529	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Zoledronate—osteoporosis	0.000525	0.000525	CcSEcCtD
Gadoversetamide—Hypertension—Estradiol—osteoporosis	0.000523	0.000523	CcSEcCtD
Gadoversetamide—Pruritus—Risedronate—osteoporosis	0.000523	0.000523	CcSEcCtD
Gadoversetamide—Nausea—Calcitriol—osteoporosis	0.000522	0.000522	CcSEcCtD
Gadoversetamide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000519	0.000519	CcSEcCtD
Gadoversetamide—Hypersensitivity—Pamidronate—osteoporosis	0.000518	0.000518	CcSEcCtD
Gadoversetamide—Chest pain—Estradiol—osteoporosis	0.000516	0.000516	CcSEcCtD
Gadoversetamide—Arthralgia—Estradiol—osteoporosis	0.000516	0.000516	CcSEcCtD
Gadoversetamide—Myalgia—Estradiol—osteoporosis	0.000516	0.000516	CcSEcCtD
Gadoversetamide—Anxiety—Estradiol—osteoporosis	0.000514	0.000514	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000513	0.000513	CcSEcCtD
Gadoversetamide—Urticaria—Zoledronate—osteoporosis	0.00051	0.00051	CcSEcCtD
Gadoversetamide—Discomfort—Estradiol—osteoporosis	0.00051	0.00051	CcSEcCtD
Gadoversetamide—Body temperature increased—Zoledronate—osteoporosis	0.000508	0.000508	CcSEcCtD
Gadoversetamide—Abdominal pain—Zoledronate—osteoporosis	0.000508	0.000508	CcSEcCtD
Gadoversetamide—Diarrhoea—Risedronate—osteoporosis	0.000506	0.000506	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000506	0.000506	CcSEcCtD
Gadoversetamide—Dry mouth—Estradiol—osteoporosis	0.000505	0.000505	CcSEcCtD
Gadoversetamide—Asthenia—Pamidronate—osteoporosis	0.000504	0.000504	CcSEcCtD
Gadoversetamide—Dizziness—Ethinyl Estradiol—osteoporosis	0.000501	0.000501	CcSEcCtD
Gadoversetamide—Confusional state—Estradiol—osteoporosis	0.000499	0.000499	CcSEcCtD
Gadoversetamide—Pruritus—Pamidronate—osteoporosis	0.000497	0.000497	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Estradiol—osteoporosis	0.000495	0.000495	CcSEcCtD
Gadoversetamide—Oedema—Estradiol—osteoporosis	0.000495	0.000495	CcSEcCtD
Gadoversetamide—Urticaria—Conjugated Estrogens—osteoporosis	0.000491	0.000491	CcSEcCtD
Gadoversetamide—Dizziness—Risedronate—osteoporosis	0.000489	0.000489	CcSEcCtD
Gadoversetamide—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000489	0.000489	CcSEcCtD
Gadoversetamide—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000489	0.000489	CcSEcCtD
Gadoversetamide—Shock—Estradiol—osteoporosis	0.000487	0.000487	CcSEcCtD
Gadoversetamide—Nervous system disorder—Estradiol—osteoporosis	0.000485	0.000485	CcSEcCtD
Gadoversetamide—Tachycardia—Estradiol—osteoporosis	0.000483	0.000483	CcSEcCtD
Gadoversetamide—Vomiting—Ethinyl Estradiol—osteoporosis	0.000482	0.000482	CcSEcCtD
Gadoversetamide—Diarrhoea—Pamidronate—osteoporosis	0.000481	0.000481	CcSEcCtD
Gadoversetamide—Skin disorder—Estradiol—osteoporosis	0.000481	0.000481	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Estradiol—osteoporosis	0.000478	0.000478	CcSEcCtD
Gadoversetamide—Rash—Ethinyl Estradiol—osteoporosis	0.000478	0.000478	CcSEcCtD
Gadoversetamide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000478	0.000478	CcSEcCtD
Gadoversetamide—Headache—Ethinyl Estradiol—osteoporosis	0.000475	0.000475	CcSEcCtD
Gadoversetamide—Hypersensitivity—Zoledronate—osteoporosis	0.000473	0.000473	CcSEcCtD
Gadoversetamide—Vomiting—Risedronate—osteoporosis	0.00047	0.00047	CcSEcCtD
Gadoversetamide—Rash—Risedronate—osteoporosis	0.000466	0.000466	CcSEcCtD
Gadoversetamide—Dermatitis—Risedronate—osteoporosis	0.000466	0.000466	CcSEcCtD
Gadoversetamide—Dizziness—Pamidronate—osteoporosis	0.000465	0.000465	CcSEcCtD
Gadoversetamide—Headache—Risedronate—osteoporosis	0.000463	0.000463	CcSEcCtD
Gadoversetamide—Asthenia—Zoledronate—osteoporosis	0.000461	0.000461	CcSEcCtD
Gadoversetamide—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000455	0.000455	CcSEcCtD
Gadoversetamide—Pruritus—Zoledronate—osteoporosis	0.000454	0.000454	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000451	0.000451	CcSEcCtD
Gadoversetamide—Nausea—Ethinyl Estradiol—osteoporosis	0.00045	0.00045	CcSEcCtD
Gadoversetamide—Insomnia—Estradiol—osteoporosis	0.000448	0.000448	CcSEcCtD
Gadoversetamide—Vomiting—Pamidronate—osteoporosis	0.000447	0.000447	CcSEcCtD
Gadoversetamide—Paraesthesia—Estradiol—osteoporosis	0.000444	0.000444	CcSEcCtD
Gadoversetamide—Asthenia—Conjugated Estrogens—osteoporosis	0.000444	0.000444	CcSEcCtD
Gadoversetamide—Rash—Pamidronate—osteoporosis	0.000443	0.000443	CcSEcCtD
Gadoversetamide—Dermatitis—Pamidronate—osteoporosis	0.000443	0.000443	CcSEcCtD
Gadoversetamide—Dyspnoea—Estradiol—osteoporosis	0.000441	0.000441	CcSEcCtD
Gadoversetamide—Headache—Pamidronate—osteoporosis	0.00044	0.00044	CcSEcCtD
Gadoversetamide—Somnolence—Estradiol—osteoporosis	0.00044	0.00044	CcSEcCtD
Gadoversetamide—Diarrhoea—Zoledronate—osteoporosis	0.000439	0.000439	CcSEcCtD
Gadoversetamide—Nausea—Risedronate—osteoporosis	0.000439	0.000439	CcSEcCtD
Gadoversetamide—Pruritus—Conjugated Estrogens—osteoporosis	0.000437	0.000437	CcSEcCtD
Gadoversetamide—Dyspepsia—Estradiol—osteoporosis	0.000436	0.000436	CcSEcCtD
Gadoversetamide—Decreased appetite—Estradiol—osteoporosis	0.00043	0.00043	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Estradiol—osteoporosis	0.000427	0.000427	CcSEcCtD
Gadoversetamide—Fatigue—Estradiol—osteoporosis	0.000427	0.000427	CcSEcCtD
Gadoversetamide—Dizziness—Zoledronate—osteoporosis	0.000425	0.000425	CcSEcCtD
Gadoversetamide—Pain—Estradiol—osteoporosis	0.000423	0.000423	CcSEcCtD
Gadoversetamide—Constipation—Estradiol—osteoporosis	0.000423	0.000423	CcSEcCtD
Gadoversetamide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000423	0.000423	CcSEcCtD
Gadoversetamide—Nausea—Pamidronate—osteoporosis	0.000418	0.000418	CcSEcCtD
Gadoversetamide—Dizziness—Conjugated Estrogens—osteoporosis	0.000409	0.000409	CcSEcCtD
Gadoversetamide—Vomiting—Zoledronate—osteoporosis	0.000408	0.000408	CcSEcCtD
Gadoversetamide—Feeling abnormal—Estradiol—osteoporosis	0.000408	0.000408	CcSEcCtD
Gadoversetamide—Rash—Zoledronate—osteoporosis	0.000405	0.000405	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Estradiol—osteoporosis	0.000405	0.000405	CcSEcCtD
Gadoversetamide—Dermatitis—Zoledronate—osteoporosis	0.000404	0.000404	CcSEcCtD
Gadoversetamide—Headache—Zoledronate—osteoporosis	0.000402	0.000402	CcSEcCtD
Gadoversetamide—Vomiting—Conjugated Estrogens—osteoporosis	0.000393	0.000393	CcSEcCtD
Gadoversetamide—Urticaria—Estradiol—osteoporosis	0.000393	0.000393	CcSEcCtD
Gadoversetamide—Body temperature increased—Estradiol—osteoporosis	0.000391	0.000391	CcSEcCtD
Gadoversetamide—Abdominal pain—Estradiol—osteoporosis	0.000391	0.000391	CcSEcCtD
Gadoversetamide—Rash—Conjugated Estrogens—osteoporosis	0.00039	0.00039	CcSEcCtD
Gadoversetamide—Dermatitis—Conjugated Estrogens—osteoporosis	0.000389	0.000389	CcSEcCtD
Gadoversetamide—Headache—Conjugated Estrogens—osteoporosis	0.000387	0.000387	CcSEcCtD
Gadoversetamide—Nausea—Zoledronate—osteoporosis	0.000381	0.000381	CcSEcCtD
Gadoversetamide—Nausea—Conjugated Estrogens—osteoporosis	0.000367	0.000367	CcSEcCtD
Gadoversetamide—Hypersensitivity—Estradiol—osteoporosis	0.000365	0.000365	CcSEcCtD
Gadoversetamide—Asthenia—Estradiol—osteoporosis	0.000355	0.000355	CcSEcCtD
Gadoversetamide—Pruritus—Estradiol—osteoporosis	0.00035	0.00035	CcSEcCtD
Gadoversetamide—Diarrhoea—Estradiol—osteoporosis	0.000339	0.000339	CcSEcCtD
Gadoversetamide—Dizziness—Estradiol—osteoporosis	0.000327	0.000327	CcSEcCtD
Gadoversetamide—Vomiting—Estradiol—osteoporosis	0.000315	0.000315	CcSEcCtD
Gadoversetamide—Rash—Estradiol—osteoporosis	0.000312	0.000312	CcSEcCtD
Gadoversetamide—Dermatitis—Estradiol—osteoporosis	0.000312	0.000312	CcSEcCtD
Gadoversetamide—Headache—Estradiol—osteoporosis	0.00031	0.00031	CcSEcCtD
Gadoversetamide—Nausea—Estradiol—osteoporosis	0.000294	0.000294	CcSEcCtD
